Furthermore, MMP14 can act as a key molecule in the CXCL10/TLR4/MMP14 signaling pathway to mobilize myeloid-derived suppressor cells and promote post-transplant HCC recurrence [53]. This evidence concerns the gene CXCL10 and hepatocellular carcinoma.